LicianPro

CLRB stock

Cellectar Biosciences Inc (CLRB) short interest & short volume · 3.4% of float short

Cellectar Biosciences Inc official short interest (FINRA, twice monthly) and daily short volume (FINRA Reg SHO), with history, % of float and days to cover.

What changed

CLRB short interest rose 58.5% to 264K shares in the Oct 15, 2026 report (3.4% of float, 1.4 days to cover). Daily short volume averaged 56.4% of volume over the last 20 sessions, the 90th percentile of its own 20-day averages since Sep 23, 2025.

Short interest

Official, twice monthly · settled Oct 15, 2026

Shares short
264K
prior 166K
% of float
3.4%
float 7.8M
Days to cover
1.4
avg vol 194K
Change vs prior report
+58.5%

6 reports

The last 24 reports (about a year) with Lician Pro.Start 3-day trial — $149/yr

Days to cover is short interest divided by FINRA's average daily volume for the period: how many average days of trading it would take shorts to buy back.

% of float uses the current float for every report (no float was stored with older reports).

Source: FINRA equity short interest (twice monthly) · Settlement Oct 15, 2026

Daily short volume

Share of each day's volume sold short · FINRA Reg SHO

Latest (Nov 2)
37.3%
16K of 44K
20-day average
56.4%
prior 56.8%
Percentile vs own history
90th
233 periods since 2025

Loading prices…

Short volumeRest of the day's volume

Source: FINRA Reg SHO daily short sale volume · Latest Nov 2, 2026

Short squeeze score (model)

Price since settlement: +10.1%

Model, not a forecast: 40 pts short interest % of float (full at 30%), 25 pts days to cover (full at 10), 15 pts rise in short interest since the prior report (full at +50%), 20 pts price gain since the settlement date (full at +25%). Missing inputs score 0.

CLRB's squeeze score and its inputs with Lician Pro.Start 3-day trial — $149/yr

Market-wide: most shorted stocks, biggest changes and unusual short volume · CLRB overview

Last 10 sessions · daily short volume · FINRA Reg SHO
DateShortTotalShort % of volume
2026-11-0216,37443,84637.3%
2026-10-3013,98424,50957.1%
2026-10-2915,18528,46453.4%
2026-10-2822,93038,83859.0%
2026-10-2725,23152,82647.8%
2026-10-2641,71181,68151.1%
2026-10-2322,78629,52377.2%
2026-10-2224,24431,52076.9%
2026-10-2156,20984,79666.3%
2026-10-2027,67143,53763.6%

Healthcare peers with similar quant ratings

CLRB among 532 rated Healthcare stocks (Lician quant rating, Nov 4, 2026). How the rating works

CLRB short interest FAQ

What is CLRB's short interest?

Cellectar Biosciences Inc (CLRB) had 264K shares sold short and not yet covered in FINRA's Oct 15, 2026 settlement report, 3.4% of its 7.8M-share float.

How many days to cover does CLRB have?

1.4 days: 264K shares short divided by an average daily volume of 194K for the Oct 15, 2026 period.

Is CLRB short interest rising or falling?

CLRB short interest rose (+58.5%) from 166K to 264K shares in the Oct 15, 2026 report.

Is CLRB a short squeeze candidate?

Lician's squeeze watch scores CLRB 31 out of 100 (low) from the Oct 15, 2026 report: short interest % of float 4.5/40, days to cover 3.4/25, change in short interest vs prior report 15/15, price change since settlement date 8.1/20. It is a transparent model of how crowded the short side is, not a forecast that a squeeze will happen.

What share of CLRB daily volume is sold short?

56.4% on average over the last 20 sessions to Nov 2, 2026 (FINRA Reg SHO daily short volume; the 90th percentile of its own 20-day averages). Short volume counts market makers' same-day short sales, so it is not short interest.

What was CLRB's latest FINRA short volume?

On Nov 2, 2026, cached FINRA short volume for Cellectar Biosciences Inc (CLRB) was 16,374 shares, 37.3% of 43,846 total volume.

How many CLRB short-volume sessions are listed on this page?

This page lists 10 cached FINRA short-volume sessions for Cellectar Biosciences Inc (CLRB), from Oct 20, 2026 through Nov 2, 2026.

How did CLRB short volume percent change from the prior cached session?

Cached FINRA short volume for Cellectar Biosciences Inc (CLRB) moved from 57.1% on Oct 30, 2026 to 37.3% on Nov 2, 2026, down 19.8 percentage points.

Not investment advice. Figures as filed or reported, not a live feed.